PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 224 filers reported holding PDL BIOPHARMA INC in Q2 2014. The put-call ratio across all filers is 0.50 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $339,000 | -78.5% | 107,980 | -75.7% | 0.05% | -73.4% |
| Q4 2015 | $1,574,000 | -4.9% | 444,724 | +35.2% | 0.18% | -6.8% |
| Q3 2015 | $1,655,000 | -18.9% | 329,050 | +3.7% | 0.19% | -5.5% |
| Q2 2015 | $2,040,000 | +45.3% | 317,236 | +58.9% | 0.20% | +3.1% |
| Q1 2015 | $1,404,000 | +93.7% | 199,620 | +112.4% | 0.20% | +101.0% |
| Q4 2014 | $725,000 | -33.5% | 93,990 | -35.6% | 0.10% | -34.9% |
| Q3 2014 | $1,090,000 | -22.9% | 145,950 | 0.0% | 0.15% | -19.9% |
| Q2 2014 | $1,413,000 | +36.8% | 145,950 | +17.5% | 0.19% | +18.5% |
| Q1 2014 | $1,033,000 | -58.3% | 124,250 | -57.6% | 0.16% | -60.9% |
| Q4 2013 | $2,475,000 | +1719.9% | 293,204 | +1619.7% | 0.40% | +1286.2% |
| Q3 2013 | $136,000 | +3.0% | 17,050 | 0.0% | 0.03% | -14.7% |
| Q2 2013 | $132,000 | – | 17,050 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Virtus ETF Advisers LLC | 158,634 | $528,000 | 0.73% |
| TFS CAPITAL LLC | 795,409 | $2,649,000 | 0.38% |
| Dynamic Capital Management Ltd | 173,813 | $579,000 | 0.22% |
| Acrospire Investment Management LLC | 91,141 | $303,000 | 0.21% |
| GSA CAPITAL PARTNERS LLP | 905,024 | $3,014,000 | 0.19% |
| RBF Capital, LLC | 273,976 | $912,000 | 0.18% |
| Gotham Asset Management, LLC | 3,732,679 | $12,430,000 | 0.14% |
| Advisors Asset Management, Inc. | 2,362,054 | $7,866,000 | 0.13% |
| A.R.T. Advisors, LLC | 812,008 | $2,703,000 | 0.12% |
| Bayesian Capital Management, LP | 37,200 | $124,000 | 0.12% |